GSK3B and ovarian cancer: For instance, downregulation of GSK3β could re-sensitize drug-resistant cells to chemotherapy [47], enhanced expression of GSK3 is associated with acquired resistance to paclitaxel in ovarian cancer [48, 49], and GSK3β inhibition can sensitize human glioblastoma cells to TMZ [22].